ALTERYX INC. A DL-,0001 WKN: A2DME9 ISIN: US02156B1035 Kürzel: AYX Forum: Aktien Thema: Hauptdiskussion

Dennoch muss man sagen dass z.B. die Prognose in Sachen Umsatz geschlagen wurde. Auch der ARR bei 22% yoy ist ordentlich

Ja, nächstes Quartal soll es einen Umsatzrückgang geben. Für ein Wachstumsunternehmen wie Alteryx in Zeiten des KI Booms natürlich gar nicht gut

versteht das jemand?

Damn, kaufe morgen nach

Habe auch gemacht

Na dann 😀 kleine Trance gekauft

Sieht eigentlich ganz gut

Full Year 2023 Guidance: Revenue is expected to be in the range of $930 million to $940 million, representing year-over-year growth of 9% to 10%. ARR is expected to be in the range of $930 million to $940 million, representing year-over-year growth of 12% to 13%. Non-GAAP income from operations is expected to be in the range of $70 million to $80 million. Non-GAAP net income per share is expected to be in the range of $0.62 to $0.72 based on approximately 76.7 million non-GAAP weighted-average diluted shares outstanding, and an effective tax rate of 20%

Third Quarter 2023 Guidance: Revenue is expected to be in the range of $208 million to $212 million, representing year-over-year decline of (4)% to (2)%. ARR is expected to be in the range of $901 million to $905 million, representing year-over-year growth of 19%. Non-GAAP income from operations is expected to be in the range of $2 million to $6 million. Non-GAAP net loss per share is expected to be in the range of $(0.08) to $(0.04) based on approximately 71.4 million non-GAAP weighted-average basic and diluted shares outstanding

Ended the second quarter of 2023 with $890 million in ARR, an increase of 22% year-over-year

Was ist los

Irrwitziger Abschlag

Minus 30%

Ziemlicher Absturz

Naja sieht nicht gut aus

Hatte gestern noch überlegt mit nem kleinen Hebel zu investieren 🙄